Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 106253001000001116 | Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 106253101000001115 | Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Is a | Ocrelizumab 300mg/10ml solution for infusion vials 1 vial | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Has AMP | Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Has specific active ingredient | Ocrelizumab | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Has dispensed dose form | Conventional release solution for infusion | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Legal category | Prescription only medicine - legal category (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial | Is a | Actual medicinal product pack | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR